Anil Kumar

9PUBLICATIONS
33CO-AUTHORS
Precision engineeringMolecular targetsNeurology and neuromuscular diseasesBiologically active moleculesOrganometallic chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 23, 2026
FDA Approval of the First-Ever PROTAC: Vepdegestrant (ARV-471) Marks a New Era in Targeted Protein Degradation.

|Mar 12, 2026
Efficient In Vivo Pharmacological Inhibition of ΔFOSB, an AP-1 Transcription Factor, in the Brain.

Sean McNeme, Anil Kumar, Yun Young Yim

|Nov 24, 2025
Efficient in vivo pharmacological inhibition of ΔFOSB, an AP1 transcription factor, in brain.

Sean McNeme, Anil Kumar, Yun Young Yim

|Nov 24, 2025
Discovery of Small Molecules and a Druggable Groove That Regulate DNA Binding and Release of the AP1 Transcription Factor ΔFOSB.

Sean McNeme, Yun Young Yim, Ashwani Kumar

|Jul 07, 2023
Divergent reactivity of sulfoxonium ylide with allyl carbonate and allyl carbamate.

Vinayak Hanchate, Sudharshan Nagabhushana Reddy, Anil Kumar

|Nov 29, 2021
Rhodium(III)-Catalyzed Cascade Reactions of Imines/Imidates with 4-Hydroxy-2-alkynoates to Synthesize Regioselective Furanone-Fused Isoquinoline Scaffolds.

Anil Kumar, Vinayak Hanchate, Kandikere Ramaiah Prabhu

Pageof 2

Frequent Collaborators

5 joint publications

Kandikere Ramaiah Prabhu

4 joint publications

Vinayak Hanchate

4 joint publications

Jia Zhou

3 joint publications

Sean McNeme